HOME
PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Mobile
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alshad S Lalani Selected Research
Alshad S Lalani Research Topics
Disease
8
Neoplasms (Cancer)
02/2009 - 01/2004
4
Anoxia (Hypoxia)
02/2009 - 04/2007
3
Neoplasm Metastasis (Metastasis)
04/2007 - 01/2004
2
Glioblastoma (Glioblastoma Multiforme)
02/2008 - 05/2006
2
Melanoma (Melanoma, Malignant)
08/2005 - 01/2004
1
Inflammation
06/2008
1
Prostatic Neoplasms (Prostate Cancer)
06/2008
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2007
1
Adenocarcinoma
04/2007
1
Disease Progression
05/2006
1
Lewis Lung Carcinoma
01/2004
Drug/Important Bio-Agent (IBA)
4
AQ4N
IBA
02/2009 - 04/2007
3
Type II DNA Topoisomerases (Topoisomerase II)
IBA
02/2009 - 02/2008
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2006 - 08/2005
2
TANDEM
IBA
02/2008 - 04/2007
1
Mitoxantrone (Novantrone)
FDA Link
Generic
02/2009
1
Blood Proteins (Serum Proteins)
IBA
06/2008
1
VA 061 (VA061)
IBA
06/2008
1
docetaxel (Taxotere)
FDA Link
06/2008
1
C-Reactive Protein
IBA
06/2008
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
02/2008
1
gemcitabine
FDA Link
Generic
04/2007
1
Prodrugs
IBA
04/2007
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
11/2006
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
05/2006
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
05/2006
1
Vascular Endothelial Growth Factor C
IBA
08/2005
1
Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
IBA
08/2005
1
Angiostatins
IBA
01/2004
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
02/2009 - 01/2004
1
Aftercare (After-Treatment)
02/2009
1
Heterologous Transplantation (Xenotransplantation)
02/2009
1
Immunotherapy
11/2006